GYRE Earnings

Quarterly EPS
$0.01
Q3 2024
$0.00
Q4 2024
$0.03
Q1 2025
$-0.02
Q2 2025
$0.04
Q3 2025
$-0.02
Q4 2025
$-0.10
Q1 2026
$-0.12
Q2 2026
Latest Revenue29.1M
Latest Net Income-14270000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.1229.1M-14270000-2.1%-500.0%
Q1 2026-$0.1022.5M-9858000+2.1%-433.3%
Q4 2025-$0.0237.2M-1366000+33.4%
Q3 2025$0.0430.6M5.9M+19.9%+300.0%
Q2 2025-$0.0229.7M-2237000+17.9%-150.0%
Q1 2025$0.0322.1M3.7M-18.8%-66.7%
Q4 2024$0.0027.9M569.0K+2.7%+100.0%
Q3 2024$0.0125.5M2.9M
Q2 2024$0.0425.2M4.5M
Q1 2024$0.0927.2M9.9M
Q4 2023-$1.3927.1M-100977000
Gyre Therapeutics (GYRE) — Earnings